🔗 Share this article

A shadow economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on TikTok, the platform has taken down violative content and prohibited associated hashtags and query recommendations. The organization stated it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a seller shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Costs

Inside these communities, posts show black plastic packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly serious medical dangers”.